This suggests that PARP1 can activate NF-κB even by endogenous signals to avert programmed cell death and emphasizes the potential beneficial effect of PARP inhibitors in combination with ionizing radiation as a tumor therapy50. This evidence concerns the gene NFKB1 and neoplasm.